Look on your insurance companys formulary list to find a weight loss medication on a lower tier, meaning lower out-of-pocket cost to you
The study, which tested the drug in 529 patients with obesity and heart failure with preserved ejection fraction (HFpEF), demonstrated a 16.6-point increase at 52 weeks, with regard to the Clinical Summary Score (CSS) on the Kansas City Cardiomyopathy Questionnaire (KCCQ) a measure of symptoms of heart failure in comparison to an 8.7-point increase in the placebo group
Researchers who have been injecting for months still make reading errors that shift their dose by 5-10%
For doctors' offices interested in learning more about our groundbreaking new product, please reach out to us via email at [email protected]
Balanced between precision and vial longevity
Brand-name semaglutide (Wegovy, Ozempic) is manufactured by Novo Nordisk, FDA-approved, and available through retail pharmacies